Ignite Creation Date:
2025-12-17 @ 3:50 PM
Ignite Modification Date:
2025-12-23 @ 9:17 PM
Study NCT ID:
NCT00747032
Status:
WITHDRAWN
Last Update Posted:
2012-05-07
First Post:
2008-09-01
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
Sponsor:
Fougera Pharmaceuticals Inc.
Organization:
Study Overview
Official Title:
Multi-Center, Double-Blind, Randomized, Vehicle-controlled, Parallel-Group Study Comparing NYC-0462 Ointment To a Vehicle Control
Status:
WITHDRAWN
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study withdrawn due to business decisions. No subjects were treated.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this trial is to assess the efficacy of NYC-0462 Ointment in the Treatment of Plaque Psoriasis.Treatment medication will be administered as follows: A thin layer of study product will be applied to the affected skin, excluding the face, once daily, at approximately the same time daily.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: